365 related articles for article (PubMed ID: 29886242)
41. Renal function and vasomotor activity in mice lacking the Cyp4a14 gene.
Fidelis P; Wilson L; Thomas K; Villalobos M; Oyekan AO
Exp Biol Med (Maywood); 2010 Nov; 235(11):1365-74. PubMed ID: 20943934
[TBL] [Abstract][Full Text] [Related]
42. Cytochrome p450 and vascular homeostasis.
Fleming I
Circ Res; 2001 Oct; 89(9):753-62. PubMed ID: 11679404
[TBL] [Abstract][Full Text] [Related]
43. Transfection of CYP4A1 cDNA increases vascular reactivity in renal interlobar arteries.
Kaide J; Wang MH; Wang JS; Zhang F; Gopal VR; Falck JR; Nasjletti A; Laniado-Schwartzman M
Am J Physiol Renal Physiol; 2003 Jan; 284(1):F51-6. PubMed ID: 12388396
[TBL] [Abstract][Full Text] [Related]
44. Role of 20-hydroxyeicosatetraenoic acid (20-HETE) in vascular system.
Miyata N; Roman RJ
J Smooth Muscle Res; 2005 Aug; 41(4):175-93. PubMed ID: 16258232
[TBL] [Abstract][Full Text] [Related]
45. Molecular mechanisms and cell signaling of 20-hydroxyeicosatetraenoic acid in vascular pathophysiology.
Fan F; Ge Y; Lv W; Elliott MR; Muroya Y; Hirata T; Booz GW; Roman RJ
Front Biosci (Landmark Ed); 2016 Jun; 21(7):1427-63. PubMed ID: 27100515
[TBL] [Abstract][Full Text] [Related]
46. 20-HETE induces remodeling of renal resistance arteries independent of blood pressure elevation in hypertension.
Ding Y; Wu CC; Garcia V; Dimitrova I; Weidenhammer A; Joseph G; Zhang F; Manthati VL; Falck JR; Capdevila JH; Schwartzman ML
Am J Physiol Renal Physiol; 2013 Sep; 305(5):F753-63. PubMed ID: 23825080
[TBL] [Abstract][Full Text] [Related]
47. Renal vascular cytochrome P450-derived eicosanoids in androgen-induced hypertension.
Singh H; Schwartzman ML
Pharmacol Rep; 2008; 60(1):29-37. PubMed ID: 18276983
[TBL] [Abstract][Full Text] [Related]
48. Combined inhibition of 20-hydroxyeicosatetraenoic acid formation and of epoxyeicosatrienoic acids degradation attenuates hypertension and hypertension-induced end-organ damage in Ren-2 transgenic rats.
Certíková Chábová V; Walkowska A; Kompanowska-Jezierska E; Sadowski J; Kujal P; Vernerová Z; Vanourková Z; Kopkan L; Kramer HJ; Falck JR; Imig JD; Hammock BD; Vanecková I; Cervenka L
Clin Sci (Lond); 2010 Feb; 118(10):617-32. PubMed ID: 20050826
[TBL] [Abstract][Full Text] [Related]
49. The Blood Pressure-Lowering Effect of 20-HETE Blockade in
Pandey V; Garcia V; Gilani A; Mishra P; Zhang FF; Paudyal MP; Falck JR; Nasjletti A; Wang WH; Schwartzman ML
J Pharmacol Exp Ther; 2017 Dec; 363(3):412-418. PubMed ID: 28912346
[TBL] [Abstract][Full Text] [Related]
50. Overexpression of cytochrome P450 4F2 in mice increases 20-hydroxyeicosatetraenoic acid production and arterial blood pressure.
Liu X; Zhao Y; Wang L; Yang X; Zheng Z; Zhang Y; Chen F; Liu H
Kidney Int; 2009 Jun; 75(12):1288-1296. PubMed ID: 19279555
[TBL] [Abstract][Full Text] [Related]
51. Role of 20-hydroxyeicosatetraenoic acid in the renal and vasoconstrictor actions of angiotensin II.
Alonso-Galicia M; Maier KG; Greene AS; Cowley AW; Roman RJ
Am J Physiol Regul Integr Comp Physiol; 2002 Jul; 283(1):R60-8. PubMed ID: 12069931
[TBL] [Abstract][Full Text] [Related]
52. Role of the CYP4A/20-HETE pathway in vascular dysfunction of the Dahl salt-sensitive rat.
Lukaszewicz KM; Lombard JH
Clin Sci (Lond); 2013 Jun; 124(12):695-700. PubMed ID: 23438293
[TBL] [Abstract][Full Text] [Related]
53. Key role of 15-lipoxygenase/15-hydroxyeicosatetraenoic acid in pulmonary vascular remodeling and vascular angiogenesis associated with hypoxic pulmonary hypertension.
Ma C; Li Y; Ma J; Liu Y; Li Q; Niu S; Shen Z; Zhang L; Pan Z; Zhu D
Hypertension; 2011 Oct; 58(4):679-88. PubMed ID: 21859965
[TBL] [Abstract][Full Text] [Related]
54. [Roles of 20-HETE on physiologic and pathologic regulation in organism].
Zhang D; Huo HL; Zhang YN; Zeng QH
Sheng Li Ke Xue Jin Zhan; 2007 Apr; 38(2):120-4. PubMed ID: 17633224
[TBL] [Abstract][Full Text] [Related]
55. Cytochrome P450 1B1 contributes to renal dysfunction and damage caused by angiotensin II in mice.
Jennings BL; Anderson LJ; Estes AM; Yaghini FA; Fang XR; Porter J; Gonzalez FJ; Campbell WB; Malik KU
Hypertension; 2012 Feb; 59(2):348-54. PubMed ID: 22184325
[TBL] [Abstract][Full Text] [Related]
56. Cytochrome P450-dependent renal arachidonic acid metabolism in desoxycorticosterone acetate-salt hypertensive mice.
Honeck H; Gross V; Erdmann B; Kärgel E; Neunaber R; Milia AF; Schneider W; Luft FC; Schunck WH
Hypertension; 2000 Oct; 36(4):610-6. PubMed ID: 11040244
[TBL] [Abstract][Full Text] [Related]
57. Smooth muscle--specific expression of CYP4A1 induces endothelial sprouting in renal arterial microvessels.
Jiang M; Mezentsev A; Kemp R; Byun K; Falck JR; Miano JM; Nasjletti A; Abraham NG; Laniado-Schwartzman M
Circ Res; 2004 Feb; 94(2):167-74. PubMed ID: 14670847
[TBL] [Abstract][Full Text] [Related]
58. Vascular actions of 20-HETE.
Hoopes SL; Garcia V; Edin ML; Schwartzman ML; Zeldin DC
Prostaglandins Other Lipid Mediat; 2015 Jul; 120():9-16. PubMed ID: 25813407
[TBL] [Abstract][Full Text] [Related]
59. Crosstalk between adenosine receptors and CYP450-derived oxylipins in the modulation of cardiovascular, including coronary reactive hyperemic response.
Nayeem MA; Hanif A; Geldenhuys WJ; Agba S
Pharmacol Ther; 2022 Dec; 240():108213. PubMed ID: 35597366
[TBL] [Abstract][Full Text] [Related]
60. [The roles of cytochrome P450 metabolites of arachidonic acid in the regulation of vascular function].
Lai JS; Chen C
Sheng Li Xue Bao; 2021 Aug; 73(4):631-645. PubMed ID: 34405219
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
